Evidence map›Paper›PMID 35434443›Full record

ArticleChronic stress (Thousand Oaks, Calif.)

Prefrontal Glutamate Neurotransmission in PTSD: A Novel Approach to Estimate Synaptic Strength in Vivo in Humans.

Lynnette A Averill, Lihong Jiang, Prerana Purohit, Anastasia Coppoli, Christopher L Averill, Jeremy Roscoe, Benjamin Kelmendi, Henk M De Feyter, Robin A de Graaf, Ralitza Gueorguieva and 5 more

Open access · goldAbstract read
In one paragraph

Article in Chronic stress (Thousand Oaks, Calif.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Reversible alterations of brain acetate metabolism associated with alcohol consumption.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Lynnette A AverillNational Center for PTSD - Clinical Neurosciences Division, US Department of Veterans Affairs, West Haven, CT, USA.ORCID https://orcid.org/0000-0002-8985-9975
Lihong JiangYale Magnetic Resonance Research Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
Prerana PurohitNational Center for PTSD - Clinical Neurosciences Division, US Department of Veterans Affairs, West Haven, CT, USA.
Anastasia CoppoliYale Magnetic Resonance Research Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
Christopher L AverillNational Center for PTSD - Clinical Neurosciences Division, US Department of Veterans Affairs, West Haven, CT, USA.ORCID https://orcid.org/0000-0001-7575-6142
Jeremy RoscoeNational Center for PTSD - Clinical Neurosciences Division, US Department of Veterans Affairs, West Haven, CT, USA.
Benjamin KelmendiNational Center for PTSD - Clinical Neurosciences Division, US Department of Veterans Affairs, West Haven, CT, USA.
Henk M De FeyterYale Magnetic Resonance Research Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
Robin A de GraafYale Magnetic Resonance Research Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
Ralitza GueorguievaDepartment of Biostatistics, School of Public Health, Yale University School of Medicine, New Haven, CT, USA.
Gerard SanacoraNational Center for PTSD - Clinical Neurosciences Division, US Department of Veterans Affairs, West Haven, CT, USA.
John H KrystalNational Center for PTSD - Clinical Neurosciences Division, US Department of Veterans Affairs, West Haven, CT, USA.
Douglas L RothmanYale Magnetic Resonance Research Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
Graeme F MasonDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Chadi G AbdallahNational Center for PTSD - Clinical Neurosciences Division, US Department of Veterans Affairs, West Haven, CT, USA.ORCID https://orcid.org/0000-0001-5783-6181
Yale University · USUnited States Department of Veterans Affairs · USMichael E. DeBakey VA Medical Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Brain Acetate and Ethanol Metabolism in Alcohol Dependence and AbuseR01AA021984 · NIAAA · YALE UNIVERSITY · PI MASON, GRAEME F. · 2013 to 2017
$2.7M
Glial and Synaptic Functions in Major DepressionR01MH112668 · NIMH · YALE UNIVERSITY · PI ABDALLAH, CHADI · 2017 to 2021
$2.4M
Examining The Effect Of Ketamine On Glutamate/Glutamine CyclingK23MH101498 · NIMH · YALE UNIVERSITY · PI ABDALLAH, CHADI · 2013 to 2017
$879k
Structural and functional neural alterations in suicidality among Veterans with PTSDIK2CX001873 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI AVERILL, LYNNETTE ASTRID · 2019 to 2023
–
CSRD VA IK2 CX001873NCATS NIH HHS UL1 TR001863NCRR NIH HHS UL1 RR024139NIAAA NIH HHS R01 AA021984NIMH NIH HHS K23 MH101498NIMH NIH HHS R01 MH112668
6 · The paper itself

Abstract

Background: Trauma and chronic stress are believed to induce and exacerbate psychopathology by disrupting glutamate synaptic strength. However, Methods: Healthy controls (n = 18) and patients with posttraumatic stress (PTSD; n = 16) completed Results: Patients with PTSD were found to have 28% reduction in prefrontal EPC ( Conclusion: The feasibility and utility of estimating prefrontal EPC using

Indexed as

depressionglutamatePTSDstresssynaptic strengthtrauma

Identifiers

PMID35434443
PMCPMC9008809
OpenAlexW4224307161

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.